Introduction: Goals and expectations of vaccination programs in beef cattle intended for show purposes

Similar documents
Introduction: Goals and expectations of vaccination programs in swine intended for show purposes

CHALLENGE VIRUS TREATMENT GROUP PI POSITIVE VIREMIA POSITIVE LEUKOPENIA POSITIVE. Vaccinates 1/22 (4.5%) 0/22 (0%) 8/22 (36.4%)

7 VETERINARY PROTOCAL INSTROUDUTION

Cattle Vaccination Programs & Immune System Functions

YOU NEED CHOICES. Elanco now brings you a comprehensive line of cattle vaccine health management solutions for your operation.

Influence of Weaning Vaccine Selection on Pre- Breeding Vaccine Options. Paul H. Walz, DVM, PhD Auburn University College of Veterinary Medicine

Vaccinations for the Beef Cattle Herd

Roberto A. Palomares DVM, MS, PhD, Dip ACT

Vaccine Protocols for the Cow Calf Producer of Central California

Maximizing your Profits in a Down Market Toby Hoffman Zoetis Territory Business Manager

Bovilis IBR Marker Live VACCINATION WITHOUT COMPLICATION

Vaccinating Heifers to Help Prevent Disease

MARKETING HEALTHY CALVES THAT STAY HEALTHY

Vaccination Recommendations Practice and Shelter-Housed Dogs

Control of Bovine Virus Diarrhoea (BVD)

ELANCO CATTLE VACCINE PORTFOLIO

USDA field safety study summary: 1

Introduction. Transmission

Use of vaccines in dairy and beef cattle production

USDA field safety study summary: 1. Intense safety in young calves: 2. High-risk stocker cattle study: 3

Proceedings, Applied Reproductive Strategies in Beef Cattle October 3 and 4, 2006, Rapid City, South Dakota

How can it affect Your operation?

Effectiveness of Vaccination Programs in Replacement Heifers

Response to Modified Live and Killed Multivalent Viral Vaccine in Regularly Vaccinated, Fresh Dairy Cows*

Proceedings, Applied Reproductive Strategies in Beef Cattle December 3-4, 2012; Sioux Falls, SD

The second-most significant disease in dairy operations. 6 22% of unweaned heifer deaths 6 46% of weaned heifer deaths 6

Best practice guide for the control of bovine respiratory disease

On The Road to Control Disease. How to Get the Most out of Your Vaccination Program. Credits. Bovine Respiratory Disease Complex BRDC

TECHNICAL BULLETIN. INFORCE 3: Prevents respiratory disease caused by bovine respiratory syncytial virus. INF January 2016

Environmental and management factors influencing BVDV antibody levels and response to vaccination in weanling calves

Respiratory Disease in Dairy and Beef Rearer Units

Credits. Immunity in the Neonate. Neonatal Immunology All food animals are immunocompetent at birth. Colostral Anti-inflammatory Cytokines

BOVINE RESPIRATORY DISEASE COMPLEX น.สพ.ฐปณ ฐ สงคส ภา สถาบ นส ขภาพส ตว แห งชาต

My presentation is about bovine neonatal diarrhea, more commonly referred to as calf scours. As always, good management is an important factor when

SUMMARY OF PRODUCT CHARACTERISTICS

Jin-An Huang VMRD Beijing

Disclosure and thanks. Vaccinating Calves: Questions. February 22, Effective Vaccination of Calves

Pro Earth Animal Health. Copyright 2017, Pro Earth Animal Health

Persistently infected BVDV animals on the dairy can contribute to a host of problems; elimination involves a two-step approach.

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1

TOC INDEX. Bovine Viral Diarrhea (BVD) Jan V. van den Hurk. Take Home Message. Introduction

TECHNICAL BULLETIN. INFORCE 3: Aids in the prevention of respiratory disease caused by infectious bovine rhinotracheitis. INF

The success story of BVD virus

Bovine Herpes Virus type 1 (BoHV-1), strain Difivac (ge-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle

TOC INDEX. Infectious Bovine Rhinotracheitis. S. van Drunen Littel - van den Hurk. Take Home Message. Introduction

Pneumonia in Beef Cattle

Control of Pestivirus Infections in Cattle. P.D. Kirkland, Virology Laboratory, EMAI

LEPTOSPIROSIS: Working with beef cattle

Investigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains

Infectious bovine rhinotracheitis: causes, signs and control options

G. INNOCENT *, I. MORRISON, J. BROWNLIE AND G. GETTINBY. (Accepted 3 February 1997)

TECHNICAL BULLETINMay 2016

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

Studies and interventions in Animals

TOC INDEX. Bovine Respiratory Syncytial Virus. John A. Ellis. Take Home Message. Cause and Spread

Biosecurity in Dairy and Beef Cattle

Pasturella and its Impact on Stocker Health. John F. Currin, DVM VMCVM

Mark Wustenberg DVM, John Kirk, DVM, MPVM, Hank Spencer DVM

GUIDELINES FOR THE VACCINATION OF DOGS

BVDFree England FAQs

The Economic Impact of BVD in a Herd. Slides available on website mid February

PCHS NEWS. When do we pool samples for testing? August When do we pool samples for testing? 1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

U.S. Breeding Cattle Exports to Vietnam Are Approved

Does your vaccination protocol compromise newborn health?

Measles and Measles Vaccine

Vaccines for Dogs. "Immunity has memory."

A guide to Pfizer. products

REDUCE the USE. of antibiotic pneumonia treatments. Vaccinate with...

BVD Overview. The Disease, Management & Control

Investigating respiratory disease

Vaccinations to optimize reproductive efficiency DCRC 2010 Minneapolis/Boise

Immunology, Vaccines, and Prevention of Salmonella

VACCINATIONS FOR FOALS

Immunity and Poultry Health (3)

NATIONAL BVD CONTROL PROGRAMME

Bovine Virus Diarrhea Virus. Jessica Seate LCS 630 Rotation

PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

Information on the voluntary phase of the Northern Ireland BVD virus eradication programme in 2013

Caring for the Future of the Herd: Raising Healthy Calves. Kate Smith, DVM Mid-Valley Veterinary Hospital Orland, CA

Additional Nutritional Considerations for Preconditioning Beef Calves 1

Vaccines - Canine

Calf pneumonia: diagnostics and vaccination protocols

guidelines types Why change? This is a disturbing trend.

STRESS AND DAIRY CALVES. Field Day, June 24, 1997 Carolyn L. Stull, Ph.D. Veterinary Medicine Extension University of California, Davis

EHV (Equine Herpes Virus) Management

This feature is provided by Life Technologies Corporation, a leading supplier of innovative biotechnology solutions

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

MATERIAL SAFETY DATA SHEET

Basic Cow Nutrition. Dr. Matt Hersom 1

UNDERSTANDING EMBRYO-TRANSFER (ET) A GUIDE TO THE BENEFIT OF ET IN YOUR HERD

Cattle Farming. Our wealth Standby team

HEALTH AND BIOSECURITY CONCERNS TO IMPROVE BEEF CATTLE REPRODUCTION

I. INTRODUCTION. The White revolution in India during the past three decades has revived the Indian

Leptospirosis has changed. Here's how to meet the new threat

Table 1: Pneumonia antibody results from calves 6-12 months of age, taken January 2015.

PROTECT YOUR INVESTMENT WITH LIFELINE. EVERY NEWBORN IS A HIGH-VALUE CALF. WHAT ARE FUNCTIONAL PROTEINS?

Section 3: Hazardous Ingredients Name CAS# % by Weight TLV/PEL LC50 / LD 50

IMMUNE SYSTEM. Biology 2201

IMMUNE SYSTEM. Biology What is a disease? Other than an injury, any change in the body that interferes with the normal functioning of the body.

Transcription:

Vaccination of Beef Cattle: A Primer... Robert M. Dyer VMD, PhD Department of Animal and Food Science College of Agriculture and Natural Resources University of Delaware Newark, Delaware, 19717-1303 Introduction: Goals and expectations of vaccination programs in beef cattle intended for show purposes A comprehensive strategy to address disease problems in show beef cattle might entail evaluation of nutrition, vaccination strategy, biosecurity practices and disease surveillance programs. In as much as proactive program of vaccination can maximize protection of the show animal against specific diseases, vaccination remains as an integral component of any strategy to maximize disease resistance in the show animal. However, be aware the show violates one of the single most important concepts in disease prevention: mixing groups of animals causes disease problems. The reason is simple: when populations of animals are assembled from a wide variety of sources and herds, many disease causing agents are assembled together as well. Disease resistance as well as disease agents, are very different within each herd and therefore the general show population represents a mixture of pathogens floating about in a population of animals with no to very high levels of resistance to each disease agent. Realistically speaking, vaccination prior to assembly will never, ever guarantee infectious disease problems will not arise in the show animals either at the show or soon after the return home. Realistically speaking, the greatest problem experienced by show animals is viral respiratory disease. The most common agents involved are Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza-3 virus (PI-3) Infectious Bovine Rhinotracheitis Virus (IBR) and Bovine Viral Diarrhea Virus (BVD). Both IBR and BVD are also potent producers of abortion in beef cattle. Thus, the goal of any vaccination program in show beef cattle should be to maximize vaccine induced immunity against these three viral agents. Vaccine induced immunity should start at a very young age and then be build upon up until weeks prior to the show season. Thus, a core program should be instituted early in newborns and boosted thereafter during several strategic times prior to the show season. Vaccination at the time of the show season or 1-2 weeks prior to the show season is never a good strategy to maximize immunity. In fact many studies show vaccine administration at a stressful time (show) while assembling a population of animals from a variety of sources (mixing animals) results in more disease problems.

Concepts and Principles behind an Essential Vaccine Program in Show Beef Cattle Minimum Essential program: The minimal basic program should include Infectious Bovine Rhinotracheitis (IBR), Parainfluenza 3 virus (PI-3), Bovine virus diarrhea virus (BVD) Bovine Respiratory Syncytial virus (BRSV) and Leptospira interrogens. Core Virus Vaccines and Vaccination programs. Killed (inactivated) vaccines vs. Modified-live vaccines (MLV): Killed Vaccines Killed vaccines are considerably less problematic because they can be administered without concern for pregnancy status and are not readily inactivated be misuse. The trade off is the level of immunity is considerably poorer than that generated by live vaccines. Duration is shorter and efficacy is lower. Inactivated vaccines are prepared with sufficient load of vaccinating agent (s) to directly stimulate the immune response. What is in the dose is all the animal will ever see during vaccination. Most killed vaccines require a booster administered 2-4 weeks after the initial exposure. Other killed vaccines may require more frequent administration (3-4 times per year). Killed vaccines generally provide an incomplete, less robust immunity. Killed vaccines are not associated with vaccine induced problems like abortion. Pathogens in killed vaccines cannot be shed to herd mates MLV Each dose of modified live vaccine does not contain sufficient load of pathogen to directly stimulate immunity. Injected pathogen must infect, disseminate throughout the host and then replicate to expand the pathogen load sufficiently to stimulate immunity. Therefore MLV vaccination is best thought of as controlled infection that the newly developing host s immune response brings under control as immunity develops. A strong immune response to the MLV clears the body of the pathogen load thereby establishing complete immunity.

Must be reconstituted with the appropriate diluents Must be used within hours after reconstitution Must be protected from environmental damage, before and during use Heat, light, improper diluents all inactivate the live vaccine Inactivated vaccines contain virtually no load of agent necessary to simulate immunity. Therefore, live agent must be administered to enable infection and expansion within the host to develop sufficient pathogen load to trigger an immune response. Administration of dead MLV vaccine prevents infection and expansion. Can cause problems in vaccinates and exposed pen-mates or herd-mates. Live pathogen load can spread to the uterus or will be shed via the conjunctive, respiratory tract and gastrointestinal tract. Pregnant herd mates or immune deficient animals will become infected with the MLV pathogen and develop disease associated problems (e.g. abortion, death). All producers need to be aware that modified live vaccines are readily destroyed by improper handling and shipping procedures. If the producer is unaware of handling procedures employed during delivery and storage of a modified live vaccines then they should never purchase the product. Modified live vaccines that sit on shipping docks, in warehouses or on delivery trucks are no longer efficacious. Assume all lay people will not understand the importance of maintaining modified live vaccines in refrigeration. Vaccines delivered in warm shipping boxes should be refused because they will no longer deliver the desired immunity.

Recommended Core Viral Vaccines and Vaccination Programs in Show Beef Cattle to Minimize Disease Problems at the Show. Viral Vaccine Schedules For Beef Cattle Group age Vaccine Comments 0-24 hours none Ingest good quality colostrum 1-2 weeks PI-3 and IBR intranasal Optional, but should use intranasal MLV vaccine. May help calves if respiratory problems exist in adults. May be inactivated by good quality colostrum. 4-6 months PI-3, IBR, BRSV and BVD MLV 9-12 months PI-3, IBR, BRSV and BVD MLV Pregnant and bred cows and heifers 40-60 days before parturition Open cows Notes and Comments: Heifers (birth to 6 months) Killed IBR, PI-3, BVD Killed PI3, IBR, BRSV and BVD most appropriate. MLV IBR, BVD, PI-3 and BRSV can be used carefully Producers should consider this the first effective vaccination of young stock. Induces a complete, robust immune response with memory. This booster is absolutely essential. Without a booster immunity from the first exposure is incomplete and ineffectual. Disease will break eventually in vaccinates not boosted as this time. Killed vaccines most appropriate-less risk of abortion in vaccinates. Maximizes protection through pregnancy. MLV is safe in vaccinates but beware, highly stressed vaccinates could shed vaccine virus to pregnant herd mates and induce abortion. Administer between 20-45 days post partum. Colostrum, colostrum, colostrum administered at 10% BW within the first 24 (preferably 6-12) hours of birth. The window for colostrum absorption is a function of gut epithelium generated just before birth. After birth this specialized epithelium is never again produced. Instead it is replaced by normal epithelium lining all post partum animals for the rest of the life. Gut epithelium is continuously replaced nearly every 24 to 36 hours. Within 24 hours of birth epithelium endowed with the ability to absorb

colostrum immunity are reduced to 20-25% of levels at birth. Colostrum immunity is no longer efficiently absorbed at that low level of epithelial presence. Best practice: provide 6 lbs colostrum within 1-3 hours of birth and an additional 5-6 lbs over the following 18 hours of birth. Employ good quality colostrum high in disease specific immunity if generated by cows exposed to a well constructed vaccine program such as that described above stored properly to prevent break down of pathogen specific antibody Bacterial Agents: Bacterial diseases are not a primary problem at the show as these diseases (leptospirosis and clostridia problems) do not normally appear at the show. Never the less, any good vaccine program for show beef cattle should include these agents in addition to those listed above. A program is presented below that will generate very high levels of protection to show animals thereby minimizing the chances of encountering problems with these agents.

Core Bacterial Vaccines and Vaccination Programs. Bacterial Vaccine Schedules for Beef Cattle Group Vaccine Comments 6 months Leptospira 5 way must include Leptospira 5 way must include L. pomona, L. canicola, L. icterohaemorrhagica, L. grippotyphosa and L. borgpetersenii serovar hardjo. Clostridia 7 way (Optional) 6 months Leptospira borgpetersenii serovar hardjo (Type: hardjo-bovis) Critical to start immunity early in young stock. Follow initial exposure with a 4 week boost. No boost----no protection! Reduces urine shedding of those born infected with L. borgpetersenii, serovar hardjo. Many 5 way vaccines may not contain the correct L. hardjo. They contain an L. hardjo strain of European origin that does not protect against urinary shedding and abortion due to L. hardj. Recently new vaccines generated from an Australian L. borgpetersenii serovar hardjo are becoming available and will generate the appropriate immunity. The Clostridia vaccine is recommended, starting in young stock. See below. Initial exposure must be followed by a boost 4-6 weeks later. No boost leads to poor immunity and protection. 12 months Leptospira 5 way must include L. pomona, L. canicola, L. icterohaemorrhagica, L. grippotyphosa and L. borgpetersenii serovar hardjo. Clostridia 7 way (Optional) Open Cows Leptospira 5 way must include L. pomona, L. canicola, L. icterohaemorrhagica,l. grippotyphosa and L. borgpetersenii serovar hardjo 40-60 days Clostridium 7 way prepartum Boost at this time is essential to generate strong immunity to protect pregnancy. Thereafter an annual boost is required 30-60 days post partum for the rest of adult life. Optional

Notes and Comments: Clostridia vaccination is often practiced in most herds. Vaccination should start at 4-6 months with boost at one year followed by annual boost thereafter.